Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2004
06/24/2004WO2002095055A3 Compositions and methods for use in isolation of nucleic acid molecules
06/24/2004WO2002092766A3 Compositions and methods for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences
06/24/2004WO2002092758A9 Gastrokines and derived peptides including inhibitors
06/24/2004WO2002086075A3 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs
06/24/2004WO2002012480B1 Yeast alpha-amylase promoter and uses thereof
06/24/2004WO2001066563A8 T1r taste receptors and genes encoding same
06/24/2004WO1999053016A3 Expression of alfin1 and methods for producing transgenic plants having increased root growth and root specific gene activation
06/24/2004US20040123350 Using expression vector comprising nucleotide sequences coding trehalose-6-phosphate synthetase (TPS) gene and trehalose-6-phosphate phosphatase (TPP) to generate dehydration, freeze and salt resistant plants
06/24/2004US20040123349 SINAT5, an Arabidopsis thaliana gene promotes ubiquitin related degradation
06/24/2004US20040123348 Comprises preparing transgenic maize, rice, barley or wheat expressing polypeptides with histone deacetylase activity for increasing transcriptional expression and propagation in plants
06/24/2004US20040123347 Water-deficit-inducible plant promoters
06/24/2004US20040123346 Basement membrane degrading proteases as insect toxins and methods of use for same
06/24/2004US20040123345 Expression vector coding polypeptide associated with binding and sequestering ionic forms of certain metals in plant tissues for controlling metal deposition in plant tissues; bioremediation
06/24/2004US20040123344 Novel gene encoding an f-box protein which regulates leaf longevity in arabidopsis thaliana and mutant gene thereof
06/24/2004US20040123342 Monocotyledonous plant transformation
06/24/2004US20040123341 Preparing transgenic corn with increased concentrations of sulfur containing compounds for improving animal feeds and viability of maize
06/24/2004US20040123339 Nucleic acid molecules and other molecules associated with transcription in plants
06/24/2004US20040123337 Method for treating an embryo
06/24/2004US20040123335 Using peptide mimetics to prevent or treat autoimmune diseases; immunotherapy
06/24/2004US20040122222 Instrument and method for collecting nucleic acids
06/24/2004US20040122216 A mutein recombinant tissue protective cytokine lacking at least one activity selected from group consisting of increasing hematocrit, vasoactive action, hyperactivating platelets, pro-coagulant activities and increasing production of thrombocytes
06/24/2004US20040122215 Human Ependymin
06/24/2004US20040121977 Antisense modulation of activating transcription factor 3 expression
06/24/2004US20040121976 Anti-inflammatory vectors
06/24/2004US20040121972 Methylenetetrahydrofolate reductase inhibitors and uses thereof
06/24/2004US20040121958 Methods of alleviating neuropathic pain
06/24/2004US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals
06/24/2004US20040121467 Elevation of fatty acid synthase levels in plants
06/24/2004US20040121466 Alphavirus RNA replicon systems
06/24/2004US20040121465 Optimization of gene sequences of virus-like particles for expression in insect cells
06/24/2004US20040121460 Pancreatic tissue culture prepared from embryonic stem cells for treatment of panreactic and diabetic disorders
06/24/2004US20040121458 Culturable mitochondrial cells with no nucleus, showing mitochondrial activity
06/24/2004US20040121444 Method of preparing recombinant adeno-associated virus compositions
06/24/2004US20040121443 Modified protamine with reduced immunogenicity
06/24/2004US20040121442 Chitin hydrolyzing enzymatic polypeptide for killing fungi, helminths, arthropods and protozoans which infect mammals and plants; disease resistant plants; fungicides
06/24/2004US20040121440 Comprises nucleotide sequences coding 5' adenylyl phosphosulphate reductase for transformation and propagation of plants with decreased sulfur limitations; enhanced nutrient quality of animal feeds
06/24/2004US20040121439 Enzymes involved in squalene metabolism
06/24/2004US20040121431 Polypeptide having alpha-isomaltosyl-transferase activity
06/24/2004US20040121430 Construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and /or developmentally regulated expression of selected genetic sequences
06/24/2004US20040121428 Transgenic corynebacterium comprising and expressing fructose phosphotransferase to use in preparation of glutamic acid and lysine; enhancing animal feeds, medicines, nutrients and cosmetics
06/24/2004US20040121411 for monitoring cleavage of beta-amyloid precursor protein (beta APP) by monitoring the fluorescent energy transfer between the adducts; for treating Alzheimer's disease
06/24/2004US20040121399 photoactivatible surface bound linker molecules which can be used to fabricate biomolecular arrays
06/24/2004US20040121397 Using prostate tissue messenger RNA to detect, diagnose, classify, monitor, prognosticate, prevent or treat cell proliferative disorders of urogenital system
06/24/2004US20040121395 Sequence #115 as a target for identifying weight modulating compounds
06/24/2004US20040121392 Method for generating a gene library
06/24/2004US20040121390 Using messenger RNA isolated from aberrant or defective tissues as diagnostic probes in disease detection
06/24/2004US20040121388 Murine cytokine receptor
06/24/2004US20040121387 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders
06/24/2004US20040121381 Identifying calcium channel modulators for treatment of autoimmune, inflammatory, allergenic, asthmatic and cell proliferative disorders
06/24/2004US20040121376 Antisense modulation of interleukin-5 signal transduction
06/24/2004US20040121373 Fragmentation of DNA
06/24/2004US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders
06/24/2004US20040121368 having genetic aptitudes beneficial to people such as seeing-eye dogs, disaster rescue dogs, assisting dogs, narcotics detection dogs, watchdogs, and pet dogs; kits
06/24/2004US20040121365 Double and triple readout assay systems
06/24/2004US20040121360 Methods, platforms and kits useful for identifying, isolating and utilizing nucleotide sequences which regulate gene exoression in an organism
06/24/2004US20040121355 Estrogen receptor genes and utilization thereof
06/24/2004US20040121354 System and method for detecting biological and chemical material
06/24/2004US20040121353 protein tyrosine phosphatase (TCPTP) for treating metabolic disorders (including diabetes and obesity), cancer, autoimmune disease, infectious and inflammatory disorders
06/24/2004US20040121348 Compositions and methods for treating pancreatic cancer
06/24/2004US20040121347 Isolation and expression of a gene for a nitrilase from Acidovorax facilis 72W
06/24/2004US20040121345 Identification of a human n-terminal acetyltransferase gene
06/24/2004US20040121344 Method of detecting nucleotide polymorphism
06/24/2004US20040121333 DNA array for high throughput solid-phase transfection and method for producing the same
06/24/2004US20040121331 for detecting protein-protein interactions; solid phase synthesis; kits
06/24/2004US20040121328 Modulation of phosphodiesterase 8A Expression
06/24/2004US20040121327 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests
06/24/2004US20040121325 Beta 1,2-xylosyltransferase-gene from arabidopsis
06/24/2004US20040121324 Barcoded synthetic lethal screening to identify drug targets
06/24/2004US20040121323 Mrna binding motif
06/24/2004US20040121322 Comparative mycobacterial genomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses
06/24/2004US20040121321 for genome mapping, gene identification and analysis, plant breeding, preparation of constructs for use in gene expression and transgenic plants
06/24/2004US20040121308 for producing the vectors and suppressing replication/reducing cytotoxicity of vector genome
06/24/2004US20040120969 The pure isolate does not suffer from the disadvantages of potential batch to batch variation between substrains and provides a product which is easier to ensure will meet consistent quality guidelines
06/24/2004US20040120957 Use of A33 antigens JAM-it
06/24/2004US20040120954 expression of PEX without a catalytic site of MT1-MMP on a cell surface directly prevents an association of two enzymes and inhibits the activation of proMMP-2 in a dose-dependent manner
06/24/2004US20040120952 Anti-TNF antibodies and peptides of human tumor necrosis factor
06/24/2004US20040120948 antibody or a functional fragment thereof that recognizes a human CD40 antigen present on the surface of human B cells, dendritic cells
06/24/2004US20040120945 Cell surface molecule mediating cell adhesion and signal transmission
06/24/2004US20040120935 Genetically modified yt cell line and use thereof
06/24/2004US20040120934 Cloned ungulate embryos and animals, use of cells tissues and organs thereof for transplantation therapies including parkinson's disease
06/24/2004US20040120930 Administering mutant epithelial nitric oxide synthase with mutation at a position corresponding to an amino acid residue in a mammalian eNOS that is phosphorylated in mammalian cells;
06/24/2004US20040120929 Defective lentivirus pseudotyped with a lyssavirus envelope; selective transfer of genes into astrocytes of central nervous system; nervous system and brain disorders; viral diseases
06/24/2004US20040120928 Composite oncolytic herpes virus vectors
06/24/2004US20040118060 Ion channel arrays
06/24/2004DE10258327A1 New artificial esterase, useful e.g. in washing compositions and for enantioselective reaction or hydrolysis of carboxylic acid derivatives, comprises that it is derived from porcine liver esterase by site-specific mutation
06/24/2004DE10256669A1 Gemisch mindestens zweier Fusionsproteine sowie ihre Herstellung und Verwendung Mixture of at least two fusion proteins and their preparation and use
06/24/2004CA2509494A1 Method of introducing sirna into adipocytes
06/24/2004CA2509465A1 Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer
06/24/2004CA2509400A1 Nk cell receptor conjugates for treating malignancies
06/24/2004CA2509387A1 Peptide oligomers for use as hiv vaccines
06/24/2004CA2509373A1 Fluorescent proteins from aquatic species
06/24/2004CA2508848A1 Human pellino polypeptides
06/24/2004CA2508808A1 Cold-induced expression vector
06/24/2004CA2508697A1 Non-human mutant mammals deficient in sigma receptors and their applications
06/24/2004CA2508632A1 Dec-205 (ly 75) / dcl-1 intergenic splice variants associated with hodgkin's disease, and uses thereof
06/24/2004CA2508631A1 Regulatory zinc finger proteins
06/24/2004CA2508204A1 Treatment of hsv-related pathologies using ssdna
06/24/2004CA2508032A1 Bentgrass event asr-368 and compositions and methods for detection thereof
06/24/2004CA2507594A1 Magnetism based nucleic acid amplification
06/24/2004CA2507554A1 Midkine-like protein